Patents
Patents for C07H 7 - Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond (2,294)
11/2001
11/08/2001WO2000050621A3 Process for producing nitrosoniom ions from a nitroxyl compound, their application in the selective oxidation of primary alcohols, and novel carbohydrate aldehydes
11/07/2001EP1152007A1 Ether type lipid a1-carboxylic acid analogues
10/2001
10/30/2001US6310200 Comprising carboxylation of an oligosaccharide using a di-tert-alkyl nitroxyl free radical as catalyst and 1,3-dibromo or -chloro-5,5-di-methylhydantoin as oxidizers at a ph of 7-1o; efficiency
10/25/2001WO2001079244A1 Pharmaceutical dopamine glycoconjugate compositions and methods of their preparation
10/17/2001EP1143981A1 Treatment and prevention of hiv and other viral infections
10/11/2001WO2001074776A1 Process for the preparation of 1,5-dideoxy-1,5-imino hexitols from oximes or imines
10/10/2001EP1142900A1 Siastatin b derivatives having glycosidase inhibitory activities and process for producing the same
10/10/2001EP1141718A1 Coupling of lipopolysaccharide-derived carbohydrates onto solid surfaces
10/10/2001EP1140958A1 Anti-(retro)viral conjugates of saccharides and acetamidino or guanidino compounds
10/10/2001EP1140737A2 System and method for structure-based drug design that includes accurate prediction of binding free energy
09/2001
09/27/2001US20010025029 Novel stromelysin inhibitors
09/19/2001CN1313861A 2-(purin-9-YL)-tetrahydrofuran-3,4-diolderivatives
09/18/2001US6291515 Use of efomycins
09/12/2001EP1131330A1 Chemiluminescent substrates for neuraminidase, assays for detection of neuraminidase and kits therefor
09/05/2001EP1000075A4 Method of producing tiazofurin and other c-nucleosides
08/2001
08/28/2001US6281202 Pharmaceutical compositions for treatment of EGF receptor associated cancers
08/21/2001US6277831 1,4-benzothiazepine-1,1-dioxide derivatives substituted by sugar residues, process for their preparation, pharmaceuticals comprising these compounds, and their use
08/10/2001WO2000047595A1 Ether type lipid a1-carboxylic acid analogues
08/10/2001CA2362246A1 Ether type lipid a1-carboxylic acid analogues
08/09/2001WO2001056563A1 Adamantyl derivatives as anti-cancer agents
08/08/2001CN1307583A Method for preparing aloin by extraction
08/01/2001CN1306511A Novel heterocyclic compounds
07/2001
07/25/2001CN1305487A Benzo (b) thiepine-1, 1-dioxide derivatives, method for production thereof, medicaments containing these compounds and their use
07/25/2001CN1305469A Benzothiepine-1, 1-dioxide derivatives, method for producing them, medicaments containing these compounds and their use
07/04/2001CN1302336A Electrodialysis methods for purifying and recovery gluconic acid derivatives
06/2001
06/28/2001DE19960640A1 Neue Stromelysin Inhibitoren New stromelysin inhibitors
06/27/2001EP1111065A2 Production of saccharide carboxylic acids
06/21/2001WO2001044264A2 Novel stromelysin inhibitors
06/21/2001WO2001044220A2 Fluorescent nucleoside analogs and combinatorial fluorophore arrays comprising same
06/21/2001WO2000061568A8 1,4-benzothiazepine-1,1-dioxide derivatives substituted by sugar radicals, methods for the production thereof, medicaments containing these compounds and the use thereof
06/13/2001CN1299373A Process for elective oxidation of primary alcohols
05/2001
05/30/2001CN1066454C Physiologically active substances of plant, process for preparation thereof, and utilities thereof
05/29/2001US6239111 Drug for treating brain diseases, enables prevention or treatment of dementia and similar diseases caused by degeneration or sloughing of neurons, an ally sulfide, sulfoxide or sulfone
05/17/2001WO2001034657A1 Process of oxidising primary alcohols
05/16/2001CN1295077A Intermediate of ganglioside GM3 analogue using fluorine to substitute sialic acid at 9-position
04/2001
04/25/2001EP1093467A1 Process for selective oxidation of primary alcohols
04/19/2001WO2001027128A1 C-aryl glucoside sglt2 inhibitors
04/19/2001WO2000061568A3 1,4-benzothiazepine-1,1-dioxide derivatives substituted by sugar radicals, methods for the production thereof, medicaments containing these compounds and the use thereof
04/18/2001EP1091970A1 Method for preparing aloin by extraction
04/17/2001US6218108 Nucleoside analogs with polycyclic aromatic groups attached, methods of synthesis and uses therefor
04/12/2001WO2001025246A2 Chromogenic substrates of sialidase of bacterial, viral, protozoa, and vertebrate origin and methods of making and using the same
04/12/2001CA2382830A1 Chromogenic substrates of sialidase of bacterial, viral, protozoa, and vertebrate origin and methods of making and using the same
04/11/2001EP1090022A1 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives
04/10/2001US6214801 Imidazo[1,2-a]pyridine C-nucleosides as antiviral agents
04/05/2001WO2001022971A1 Sebum production inhibitors
04/05/2001CA2385493A1 Sebum production inhibitors
03/2001
03/28/2001EP1086938A2 Oxidation of alcohols mediated by nitroxyl derivatives
03/28/2001EP1086113A2 Benzothiepine-1,1-dioxide derivatives, method for producing them, medicaments containing these compounds and their use
03/28/2001EP1086112A2 1-galactose derivatives
03/28/2001EP1086092A1 BENZO(b)THIEPINE-1,1-DIOXIDE DERIVATIVES, A METHOD FOR THE PRODUCTION THEREOF, MEDICAMENTS CONTAINING THESE COMPOUNDS, AND THEIR USE
03/22/2001WO2001019960A1 Recombinant microorganisms expressing an oligosaccharide receptor mimic
03/22/2001CA2384081A1 Recombinant microorganisms expressing an oligosaccharide receptor mimic
03/21/2001EP1084264A1 Electrodialysis methods for purification and recovery of gluconic acid derivatives
03/20/2001US6203792 Composition and methods using myelin-associated glycoprotein (MAG) and inhibitors thereof
03/08/2001WO1999061647A9 Electrodialysis methods for purification and recovery of gluconic acid derivatives
03/06/2001US6197752 Tetrahydrofuran or tetrahydropyran compound; therapy for autoimmune disease, antiallergens, antiinflammatory agents
02/2001
02/28/2001EP1078932A2 Process for the preparation of 2-keto-2-gulonic acid esters
02/28/2001CN1285342A Process for preparation of 2-keto-gulonoester
02/27/2001CA2110582C Modified sialyl lewis a compounds
02/22/2001DE19938980A1 Verfahren zur Herstellung von 2-Keto-L-gulonsäureestern A process for producing 2-keto-L-gulonic esters
02/20/2001US6191271 Synthetic divalent sLex containing polylactosamines and methods for use
02/13/2001US6187570 Removing 2,4 keto-d-gluconic acid, 2,5 diketo-d-gluconic acid, idonic acid, 2-keto-l-gulonic acid, vanillic acid or ascorbic acid from non-viable, acidic fermentation medium using electrodialysis
02/08/2001WO2001009152A1 Process for purifying 2-keto-l-gulonic acid
02/08/2001CA2388299A1 Process for purifying 2-keto-l-gulonic acid
01/2001
01/16/2001US6174867 Inhibition of the binding of a toxin or organism to its corresponding cell surface receptor; e.g., heat-labile enterotoxin or cholera toxin or enterovirulent organisms; bactericides, viricides, fungicides
01/11/2001DE19916108C1 Mit Zuckerresten substituierte 1,4-Benzothiazepin-1,1-dioxidderivate, Verfahren zu deren Herstellung und deren Verwendung With sugar residues substituted 1,4-benzothiazepine-1,1-dioxide derivatives, processes for their preparation and their use
01/04/2001WO2001000217A1 Medicinal compositions for preventing or treating diarrhea
01/04/2001WO2000039751A3 System and method for structure-based drug design that includes accurate prediction of binding free energy
01/04/2001WO2000018777A3 Method for synthesizing c-glycosides of ulosonic acids
01/04/2001CA2376938A1 Medicinal compositions for preventing or treating diarrhea
01/02/2001US6168934 Oligosaccharide enzyme substrates and inhibitors: methods and compositions
12/2000
12/27/2000EP1062362A1 Levo-monosaccharide in a nucleoside analog for use as an antiretroviral agent
12/21/2000WO1999061647A8 Electrodialysis methods for purification and recovery of gluconic acid derivatives
12/14/2000WO2000074674A1 Novel porphyrin derivatives for photodynamic therapy
12/05/2000US6156326 Dermatological preparations, emulsifiers, water-free concentrate cleansers, aqueous cleansers, detergent surfactants
11/2000
11/28/2000US6153791 Process for purifying 2-keto-L-gulonic acid
11/09/2000WO2000066601A1 Method for preparing aloin by extraction
11/07/2000US6143533 Method for the preparation of N-glycolyl neuraminic acid from Cucumaria echinata
10/2000
10/31/2000US6140480 Adduct of hoffer's chlorosugar comprising an organocadmium or organozinc derivative of pyrene, anthracene, phenanthrene, stilbene, tetracene, or pentacene coupled to the c1 position; fluorescent probes
10/31/2000US6140307 Pharmaceutical composition
10/24/2000CA2024497C Chemical derivatives of antibiotics ll-f19020 alpha and beta
10/19/2000WO2000061640A1 Process for the preparation of autocrosslinked compounds of hyaluronic acid and the derivatives thereof by the supercritical antisolvent technique
10/19/2000WO2000061568A2 1,4-benzothiazepine-1,1-dioxide derivatives substituted by sugar radicals, methods for the production thereof, medicaments containing these compounds and the use thereof
10/10/2000US6130326 L-ribavirin. oh; anticarcinogenic/antitumor agents; viricides; fungicides; treatment of autoimmune diseases
09/2000
09/28/2000WO2000056734A1 Bicyclic heterocycles, method for producing them and their use as herbicides and pharmaceutical agents
09/27/2000CN1268140A Monocyclic L-nucleosides, analogs and uses thereof
09/21/2000DE19912636A1 Bicyclische Heterocyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Herbizide und pharmazeutische Mittel Bicyclic heterocycles, process for their preparation and their use as herbicides and pharmaceutical compositions
09/19/2000CA2141679C New derivatives of neuraminic acid
09/11/2000CA2265247A1 Use of efomycins
08/2000
08/31/2000WO2000050621A2 Process for producing nitrosoniom ions from a nitroxyl compound, their application in the selective oxidation of primary alcohols, and novel carbohydrate aldehydes
08/31/2000WO2000050388A1 Process for producing nitrosonium ions
08/31/2000CA2362717A1 Process for selective oxidation of primary alcohols and novel carbohydrate aldehydes
08/29/2000US6111084 Sialyl lewis mimetics produced by solid phase synthesis; antiinflammatory agents
08/29/2000US6110897 Cleavage of the two acetamido functional groups in the sialic acid and n-acetylglucosamine moieties of oligosaccharides containing sialyl-lewis x and sialyl-lewis a structures; resulting oligosaccarides bind selectins with high affinity
08/16/2000EP1027359A2 Monocyclic l-nucleosides, analogs and uses thereof
08/02/2000CN1055092C Preparation of gluconic acid by hydrogen peroxide oxidizing process
08/01/2000CA2028117C Substance trehalostatin and process for the preparation thereof
07/2000
07/26/2000CN1261370A Method of producing tiazofurin and other C-nucleosides
07/19/2000EP1019425A1 Modified benzimidazole nucleosides as antiviral agents
07/18/2000US6090602 Inhibiting hybridization of a reverse-transcribing dna strand with an rna template by delivering 1'-adenyl-, 1'-cytodinyl-, 1'-guanyl-, 1'-thymidyl-, or 1'-uridinyl-l-rhamnose; analog is phorphorylated and incorporated into synthesized dna
1 ... 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23